Keyphrases
Clinical Trials
100%
Core Outcome Set
87%
Patient Outcomes
49%
Cost-savings Potential
43%
Risk Outcomes
43%
Knee Osteoarthritis
43%
Medicare Part D
43%
Risk-benefit
43%
Diabetes Medications
43%
Macular Degeneration
43%
Patient Benefit
43%
Drug Development
43%
Cost-plus
43%
Cuban
43%
Drug Companies
43%
Hip Osteoarthritis
43%
Patient Risk
43%
Afatinib
43%
Medicare
29%
Osteoarthritis
25%
Trialists
18%
Drug Costs
14%
Adverse Events
12%
Treatment Burden
12%
Descriptive Statistics
12%
Number of Trials
12%
Clinical Practice
12%
Non-small Cell Lung Cancer (NSCLC)
12%
Inferential Statistics
12%
Metformin
9%
Treatment Type
9%
Uncorrected Distance Visual Acuity
9%
Treatment Complications
9%
Number of Treatment
9%
Cost Savings
9%
Cost Difference
9%
Clinical Outcomes
6%
Patient Response
6%
Outcome Reporting
6%
Research Electronic Data Capture (REDCap)
6%
Informed Consent
6%
Breast Cancer Cells
6%
Relationship between Variables
6%
Literature Database
6%
Recurring
6%
Survey Response
6%
Clinical Application
6%
Off-label Use
6%
20 Questions
6%
Researcher Perspective
6%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
87%
Afatinib
43%
Diabetes Mellitus
43%
Drug Development
43%
Macular Degeneration
43%
Malignant Neoplasm
43%
Metformin
43%
Prevalence
21%
Prescription Drug
21%
Drug Screening
21%
Generic Drug
21%
Disease
14%
Adverse Event
12%
Lung Cancer
12%
Bleeding
8%
Vasculotropin
8%
Edema
8%
Squamous Cell Carcinoma
6%
Breast Cancer
6%
Off-Label Use
6%
Monotherapy
6%
Nursing and Health Professions
Osteoarthritis
43%
Knee Osteoarthritis
43%
Cost Control
43%
Cross-Sectional Study
43%
Medicare
43%
Hip Osteoarthritis
43%
Drug Therapy
43%
Inferential Statistics
17%
Clinical Practice
17%
Metformin
10%
Diabetes Mellitus
10%
Treatment Outcome
8%
Thematic Analysis
8%
Student T Test
8%
Chi Square Test
8%
Disease
8%
Drug Cost
5%
Generic Drug
5%
Data Extraction
5%
Drug Screening
5%
Prescription Drug
5%
Reproducibility
5%
Prevalence
5%
